Literature DB >> 15654865

A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.

Robert Adalbert1, Thomas H Gillingwater, Jane E Haley, Katherine Bridge, Bogdan Beirowski, Livia Berek, Diana Wagner, Daniela Grumme, Derek Thomson, Arzu Celik, Klaus Addicks, Richard R Ribchester, Michael P Coleman.   

Abstract

The slow Wallerian degeneration phenotype, Wld(S), which delays Wallerian degeneration and axon pathology for several weeks, has so far been studied only in mice. A rat model would have several advantages. First, rats model some human disorders better than mice. Second, the larger body size of rats facilitates more complex surgical manipulations. Third, rats provide a greater yield of tissue for primary culture and biochemical investigations. We generated transgenic Wld(S) rats expressing the Ube4b/Nmnat1 chimeric gene in the central and peripheral nervous system. As in Wld(S) mice, their axons survive up to 3 weeks after transection and remain functional for at least 1 week. Protection of axotomized nerve terminals is stronger than in mice, particularly in one line, where 95-100% of neuromuscular junctions remained intact and functional after 5 days. Furthermore, the loss of synaptic phenotype with age was much less in rats than in mice. Thus, the slow Wallerian degeneration phenotype can be transferred to another mammalian species and synapses may be more effectively preserved after axotomy in species with longer axons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654865     DOI: 10.1111/j.1460-9568.2004.03833.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  42 in total

Review 1.  Wallerian degeneration, wld(s), and nmnat.

Authors:  Michael P Coleman; Marc R Freeman
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

2.  Wallerian degeneration of zebrafish trigeminal axons in the skin is required for regeneration and developmental pruning.

Authors:  Seanna M Martin; Georgeann S O'Brien; Carlos Portera-Cailliau; Alvaro Sagasti
Journal:  Development       Date:  2010-11-01       Impact factor: 6.868

Review 3.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

4.  The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus.

Authors:  Heike Laser; Laura Conforti; Giacomo Morreale; Till G M Mack; Molly Heyer; Jane E Haley; Thomas M Wishart; Bogdan Beirowski; Simon A Walker; Georg Haase; Arzu Celik; Robert Adalbert; Diana Wagner; Daniela Grumme; Richard R Ribchester; Markus Plomann; Michael P Coleman
Journal:  Mol Biol Cell       Date:  2005-12-21       Impact factor: 4.138

5.  Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons.

Authors:  Jonathan Gilley; Michael P Coleman
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

6.  In vivo nerve-macrophage interactions following peripheral nerve injury.

Authors:  Allison F Rosenberg; Marc A Wolman; Clara Franzini-Armstrong; Michael Granato
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

Review 7.  Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme.

Authors:  Rong Grace Zhai; Menico Rizzi; Silvia Garavaglia
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

8.  Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-dose.

Authors:  Ann K Wright; Thomas M Wishart; Cali A Ingham; Thomas H Gillingwater
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

9.  Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.

Authors:  Catherine Kielar; Thomas M Wishart; Alice Palmer; Sybille Dihanich; Andrew M Wong; Shannon L Macauley; Chun-Hung Chan; Mark S Sands; David A Pearce; Jonathan D Cooper; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2009-07-29       Impact factor: 6.150

10.  Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues.

Authors:  Thomas M Wishart; David G Brownstein; Derek Thomson; Anca M Tabakova; Katherine M Boothe; Jack W Tsao; Thomas H Gillingwater
Journal:  BMC Neurosci       Date:  2009-12-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.